Astellas Pharma Inc. (ALPMY) has a market capitalization of $28.7B and trades at $16.02. The 52-week range is 8.37-17.35.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.6, Earnings Per Share (EPS) of $28.35, annual revenue of $1.91T.
The stock has a beta of 0.15, a last dividend of $0.5100, operates in the Healthcare sector.
